(Q34340099)

1 August 2017

1 reference

title

Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency (English)

1 reference

1 August 2017

A A Ramelet

1

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

52 Suppl 1

1 reference

1 August 2017

page(s)

S49-56

1 reference

Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

Neutrophil activation and mediators of inflammation in chronic venous insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

Inflammation in chronic venous insufficiency. Is the problem insurmountable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319701052001S07

10.1177/0003319701052001S07

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference